Jun-13296

N/A

Report date: 2026/05/27 17:57:54
NME

Base Information

Drug NameJun-13296
Drug Alias NameJun-13296Jun13296
ClassificationSmall molecules
Mechanisms of ActionSARS-CoV-2 PLpro inhibitors
TargetsSARS-CoV-2 papain-like protease
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOklahoma State UniversityRutgers University
China Registration ClassN/A

Develop Information

Active CompaniesOklahoma State UniversityRutgers University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A